{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:17:19Z","timestamp":1760782639479},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1987,5,1]],"date-time":"1987-05-01T00:00:00Z","timestamp":546825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":10442,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1987,5]]},"DOI":"10.1111\/1523-1747.ep12470088","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T10:15:44Z","timestamp":1090491344000},"page":"535-537","source":"Crossref","is-referenced-by-count":7,"title":["Inhibition of Transformation by Levodopa-Carbidopa in Lymphocytes Derived From Patients With Melanoma"],"prefix":"10.1016","volume":"88","author":[{"given":"Michael M.","family":"Wick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12470088_bb0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.877570","article-title":"Selective toxicity for melanoma cells in vitro","volume":"197","author":"Wick","year":"1977","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12470088_bb0015","first-page":"1657","article-title":"Therapeutic effect of dopamine infusion upon human malignant melanoma","volume":"66","author":"Wick","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/1523-1747.ep12470088_bb0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.1978.03290060056015","article-title":"Levodopa therapy and malignant melanoma","volume":"240","author":"Sober","year":"1978","journal-title":"JAMA"},{"key":"10.1111\/1523-1747.ep12470088_bb0025","first-page":"41","article-title":"New approaches to the chemotherapy of malignant melanoma","volume":"6","author":"Wick","year":"1986","journal-title":"Primary Care and Cancer"},{"key":"10.1111\/1523-1747.ep12470088_bb0030","first-page":"1465","article-title":"3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B-16 melanoma","volume":"63","author":"Wick","year":"1979","journal-title":"JNCI"},{"key":"10.1111\/1523-1747.ep12470088_bb0035","first-page":"861","article-title":"Levodopa and dopamine analogs: dihydroxy- and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo","volume":"65","author":"Wick","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/1523-1747.ep12470088_bb0040","first-page":"155","article-title":"Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future","volume":"2","author":"Gutterman","year":"1975","journal-title":"Semin Oncol"},{"key":"10.1111\/1523-1747.ep12470088_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0090-1229(75)90097-5","article-title":"Differentiation between B cells, T cells, and histiocytes in melanoncytic lesions; primary and metastatic melanoma and halo and giant pigmented nevi","volume":"4","author":"Edelson","year":"1975","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1111\/1523-1747.ep12470088_bb0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0733-8635(18)30907-0","article-title":"Immunology and immunotherapy of human malignant melanoma","volume":"3","author":"Bystryn","year":"1985","journal-title":"Dermatol Clin"},{"key":"10.1111\/1523-1747.ep12470088_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1432-0436.1985.tb00510.x","article-title":"Vitiligo related pigment cell differentiation antigens are expressed on malignant melanoma cells following phenotypic reversion induced by contact inhibitory factor","volume":"30","author":"Lipkin","year":"1985","journal-title":"Differentiation"},{"key":"10.1111\/1523-1747.ep12470088_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/52.1.19","article-title":"Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case report","volume":"52","author":"Mastrangelo","year":"1974","journal-title":"JNCI"},{"key":"10.1111\/1523-1747.ep12470088_bb0065","first-page":"543","article-title":"Regression of malignant melanoma as a manifestation of a cellular immunity response","volume":"62","author":"Lloyd","year":"1969","journal-title":"Proc R Soc Med"},{"key":"10.1111\/1523-1747.ep12470088_bb0070","first-page":"155","author":"Mastrangelo","year":"1976"},{"key":"10.1111\/1523-1747.ep12470088_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archneur.1981.00510010045007","article-title":"Herpesviruses and parkinsonism. Herpes simplex virus types 1 and 2, and cytomegalovirus antibodies in serum and CSF","volume":"38","author":"Marttila","year":"1981","journal-title":"Arch Neurol"},{"key":"10.1111\/1523-1747.ep12470088_bb0080","first-page":"227","article-title":"Virus antibodies in Parkinson's disease. Herpes simplex and measles virus antibodies in serum and CSF and their relation to HLA types","volume":"54","author":"Mantilla","year":"1982","journal-title":"J Neurol Sci"},{"key":"10.1111\/1523-1747.ep12470088_bb0085","first-page":"221","article-title":"Parkinson's disease, dysautonomy, and auto antibodies directed against sympathetic neurons","volume":"136","author":"Emile","year":"1980","journal-title":"Rev Neurol"},{"key":"10.1111\/1523-1747.ep12470088_bb0090","first-page":"31","article-title":"Isolation of leukocytes from human blood","volume":"21","author":"Boyum","year":"1968","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/1523-1747.ep12470088_bb0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1523-1747.ep12531751","article-title":"3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to DNA polymerase","volume":"80","author":"FitzGerald","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12470088_bb0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0006-2952(85)90043-7","article-title":"Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamine","volume":"34","author":"FitzGerald","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/1523-1747.ep12470088_bb0105","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM198004103021502","article-title":"Methyldopa inhibition of suppressor lymphocyte function","volume":"302","author":"Kirtland","year":"1980","journal-title":"N Engl J Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X87901588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X87901588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T20:36:34Z","timestamp":1585859794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X87901588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987,5]]}},"alternative-id":["S0022202X87901588"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12470088","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1987,5]]}}}